Gold Holds Near $4,275 as Rising Treasury Yields Fuel Fed Rate Hike Bets 
Trump, Xi Focus on Trade and AI at White House Summit 
U.S. Treasury Yields Surge as 30-Year Hits 22-Year High 
North Korea Rejects Nuclear Test Warning, Calls Nuclear Status Irreversible 
Judge Orders Trump to Restore White House Access for CNN, MS NOW and Politico 
Xi Calls for Deeper U.S.-China AI Cooperation in Trump Talks 
North Korea Warns South Korea Over US-Led Defense Role 
Russian Missile and Drone Attack on Kyiv Kills Two, Damages Maternity Hospital 
China’s ‘Lipstick King’ Says AI Won’t Replace Livestream Hosts 
Wall Street Ends Flat as Oil, Treasury Yields and Fed Jitters Rattle Markets 
Saudi Arabia, Turkey and Pakistan Plan Urgent Defence Talks Over Houthi Attacks 
Mexico-US Trade Talks Delayed to October as Tariff Negotiations Continue 
Australia Unemployment Hits Five-Year High Despite Strong Jobs Growth 
OpenAI Agent Breaches Australia Medicare Data Portal 
NATO Boosts Intelligence Sharing Amid Russia Hybrid Threats 
Sudan Rejects US Legitimacy Remarks, Defends Sovereignty 
Add as a preferred source on Google
Indonesia is reportedly pushing back against U.S. efforts to introduce so-called “poison pill” clauses into a proposed reciprocal tariff trade agreement, according to a Financial Times report citing individuals familiar with the ongoing negotiations. These clauses are designed to discourage U.S. trading partners from deepening economic ties with China—part of Washington’s broader strategy to counter Beijing’s growing influence across Southeast Asia.
While Reuters has not yet independently verified the report, the development highlights rising geopolitical competition between the United States and China, particularly in regions where both powers seek strategic and economic footholds. For Indonesia, maintaining balanced relationships is crucial. As one of Southeast Asia’s largest economies, Indonesia relies heavily on foreign investment and global trade, including significant economic cooperation with both the U.S. and China.
Washington’s proposed “poison pill” mechanism would reportedly penalize Indonesia if it entered into future trade agreements with China deemed unfavorable by the U.S. The concept mirrors provisions the U.S. previously implemented under the renegotiated NAFTA deal—now known as the USMCA—which included restrictions aimed at curbing members’ trade engagement with non-market economies.
Indonesia’s resistance signals its intent to preserve strategic autonomy. Officials reportedly view such clauses as potentially limiting the country’s economic flexibility and undermining its long-standing goal of maintaining a neutral and diversified foreign policy. Analysts believe Jakarta is cautious about taking steps that could jeopardize its extensive trade relationship with China, which remains one of Indonesia’s top trading partners and a major investor in infrastructure projects.
The negotiations come as the U.S. increasingly works to strengthen economic partnerships in the Indo-Pacific to counter China’s influence. How both sides navigate these disagreements may shape the future of regional trade dynamics and U.S.–Indonesia economic relations.
